Maze Therapeutics to Present Preclinical Data Highlighting MZE001 as a Potential Treatment for Pompe Disease at 2022 WORLD Symposium
Maze Therapeutics to Present Preclinical Data Highlighting MZE001 as a Potential Treatment for Pompe Disease at 2022 WORLD Symposium SOUTH SAN FRANCISCO, CA., January 31, 2022 – Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced…